相关实验视频

Updated: May 5, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

人类乳头瘤病毒自取样在亚洲:一个系统的审查

Xuechao Ji¹, Menglin Hao¹, Yixiao Wang¹

¹Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Beijing Maternal and Child Health Care Hospital, Capital Medical University, Beijing, China.

Frontiers in microbiology

|March 31, 2025

概括

人类乳头瘤病毒 (HPV) 自取样是传统宫癌查的准确替代方案. 这种方法在亚洲女性中显示出高准确度和接受度,改善了查覆盖率.

科学领域:

妇科妇科妇科妇科
在瘤学瘤学.
公共卫生公共卫生

背景情况:

宫癌查对于早期发现和预防至关重要.
人类乳头瘤病毒 (HPV) 检测是宫癌查的主要方法.
HPV自取样为临床医生收集的样本提供了一个潜在的有效替代方案.

研究的目的:

系统地审查和比较HPV自取样与亚洲临床医生采样的准确性和接受性.
评估自己和临床医生收集的HPV检测样本之间的一致性.
评估女性对HPV自取样本的偏好和担忧.

主要方法:

从主要数据库 (PubMed,Cochrane,CINAHL,Web of Science) 中对到2023年发布的研究进行系统审查.
包括评估HPV自取样准确度,接受度和同意亚洲临床医生采样的研究.
使用QUADAS-2工具评估偏差风险;通过敏感性,特异性和HPV检测率来衡量准确性.

主要成果:

分析了67项涉及117,279名参与者的研究.
HPV自取样显示高准确度 (灵敏度>80%,特异性>70%) 与临床医生采样相比较.
在自我和临床医生收集的样本之间观察到很高的一致性 (kappa>0.7),女性表现出很高的接受度,但有一些担忧.

结论:

HPV自取样可以显著增加宫癌查覆盖率,特别是在资源有限的环境中或医生采样接受度较低的地方.
虽然一般准确且被接受,但对于中国和印度等特定地区,可能需要对诊断标准和HPV检测方法进行调整.
建议有针对性的健康教育,以进一步提高女性接受和采用HPV自取样的程度.

关键词:

亚洲亚洲亚洲亚洲宫癌:子宫癌是一种癌症.临床医生采样采样人类乳头瘤病毒人类乳头瘤病毒查检查查检查查检查查检查自我采样自动采样

更多相关视频

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 12, 2014

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...